329
Participants
Start Date
April 29, 2016
Primary Completion Date
April 14, 2018
Study Completion Date
December 31, 2028
Genetic SNP profiling
Genetic SNP profiling of known prostate cancer predisposition SNPs will be performed on DNA extracted from saliva samples.
Prostate cancer screening
Prostate cancer screening in the form of PSA testing will be offered to all men who have a benign biopsy result for five years in order to track development of cancer in the future.
Prostate biopsy
Prostate biopsy will be offered to men identified within the top 10% genetic risk score profile.
Institute of Cancer Research and Royal Marsden Hospital, Sutton
Institute of Cancer Research, United Kingdom
OTHER